HIT Consultant December 29, 2025
In today’s pharmaceutical industry, real-world evidence (RWE) offers significant potential across all phases of the product life cycle, from trial design to product launch, from pricing and competitive reviews to evaluating the effects of switching medications.
As RWE becomes a key tool for life sciences organizations to shape clinical trial strategies, advance treatment development, and meet regulatory requirements, the quality of the underlying data and trust in how it was generated is paramount.
While just about everyone claims to use artificial intelligence (AI) to extract and curate real-world data (RWD) from healthcare systems, how do you know what to look for, who to trust, or what questions to ask when seeking to generate RWE?
In other words, what’s actually happening...
Today's Sponsors
Today's Sponsor